{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:23:13Z","timestamp":1794090193908,"version":"4.8.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["24-15-00066"],"award-info":[{"award-number":["24-15-00066"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.antiviral.2026.106550","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:04:41Z","timestamp":1791389081000},"page":"106550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A novel antiviral drug candidate acts by binding to the hemagglutinin stem"],"prefix":"10.1016","volume":"255","author":[{"given":"Natalia","family":"Monakhova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav","family":"Lobanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem","family":"Poromov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lepioshkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Riabova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kazakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Pomeshikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Leneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandrina","family":"Volobueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3645-8342","authenticated-orcid":false,"given":"Iana","family":"Esaulkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Lavrentieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Shtro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Galochkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Komissarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Khrenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8746-2694","authenticated-orcid":false,"given":"Vadim","family":"Makarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2026.106550_bib1","article-title":"Influenza therapeutics in clinical practice-challenges and recent advances","volume":"1","author":"Beigel","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.antiviral.2026.106550_bib2","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1021\/ct300400x","article-title":"Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone \u03d5, \u03c8 and side-chain \u03c71 and \u03c72 dihedral angles","volume":"8","author":"Best","year":"2012","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.antiviral.2026.106550_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13321-021-00548-6","article-title":"ProLIF: a library to encode molecular interactions as fingerprints","volume":"13","author":"Bouysset","year":"2021","journal-title":"J. Cheminf."},{"key":"10.1016\/j.antiviral.2026.106550_bib4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3390\/ph14060587","article-title":"Small molecule inhibitors of influenza virus entry","volume":"14","author":"Chen","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.antiviral.2026.106550_bib5","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2174\/0113895575401074250923075239","article-title":"Small molecule influenza virus fusion inhibitors targeting viral hemagglutinin: Chemical insights and antiviral evaluation","volume":"25","author":"\u00c7\u0131nar","year":"2025","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.antiviral.2026.106550_bib6","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/jcc.21777","article-title":"Impact of 2\u2032\u2010hydroxyl sampling on the conformational properties of RNA: update of the CHARMM all\u2010atom additive force field for RNA","volume":"32","author":"Denning","year":"2011","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.antiviral.2026.106550_bib7","article-title":"An orally active entry inhibitor of influenza A viruses protects mice and synergizes with oseltamivir and baloxavir marboxil","volume":"23","author":"Gaisina","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.antiviral.2026.106550_bib8","article-title":"Hemagglutinin structure and activities","volume":"1","author":"Gamblin","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.antiviral.2026.106550_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF00766445","article-title":"Molecular biological characteristics of the action of arbidol \u2014 a new antiviral drug","volume":"26","author":"Glushkov","year":"1992","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.antiviral.2026.106550_bib10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/v10040184","article-title":"Arbidol (Umifenovir): a broad-spectrum antiviral drug that inhibits medically important arthropod-borne flaviviruses","volume":"10","author":"Haviernik","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2026.106550_bib11","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.antiviral.2026.106550_bib12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1073\/pnas.1617020114","article-title":"Structural basis of influenza virus fusion inhibition by the antiviral drug arbidol","volume":"10","author":"Kadam","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2026.106550_bib13","article-title":"Next-generation influenza vaccines","volume":"2","author":"Kanekiyo","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.antiviral.2026.106550_bib14","article-title":"Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry","volume":"28","author":"Kitamura","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2026.106550_bib15","first-page":"1201","article-title":"Influenza and antiviral resistance: an overview","volume":"39","author":"Lampejo","year":"2020","journal-title":"Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.antiviral.2026.106550_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.antiviral.2008.10.009","article-title":"Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol","volume":"81","author":"Leneva","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2026.106550_bib18","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3390\/v13081665","article-title":"Antiviral activity of umifenovir in vitro against a broad spectrum of coronaviruses, including the novel SARS-CoV-2 virus","volume":"23","author":"Leneva","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2026.106550_bib17","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/jmv.25358","article-title":"Umifenovir susceptibility monitoring and characterization of influenza viruses isolated during ARBITR clinical study","volume":"91","author":"Leneva","year":"2019","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2026.106550_bib19","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1073\/pnas.78.7.4133","article-title":"Interaction of influenza virus hemagglutinin with target membrane lipids is a key step in virus-induced hemolysis and fusion at pH 5.2","volume":"78","author":"Maeda","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2026.106550_bib21","doi-asserted-by":"crossref","DOI":"10.1063\/5.0014475","article-title":"Scalable molecular dynamics on CPU and GPU architectures with NAMD","volume":"153","author":"Phillips","year":"2020","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.antiviral.2026.106550_bib22","article-title":"A phase III, randomized, double-blind, placebo controlled trial to evaluate the efficacy and safety of nitazoxanide in the treatment of uncomplicated influenza","author":"Romark Laboratories","year":"2022","journal-title":"ClinicalTrials.gov identifier: NCT0333661"},{"key":"10.1016\/j.antiviral.2026.106550_bib23","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038356","article-title":"Human influenza epidemiology","volume":"11","author":"Ryu","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.antiviral.2026.106550_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF00772858","article-title":"Synthesis of a new antiviral agent, arbidol","volume":"27","author":"Trofimov","year":"1993","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.antiviral.2026.106550_bib25","article-title":"A small-molecule fusion inhibitor of influenza virus is orally active in mice","volume":"8","author":"van Dongen","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2026.106550_bib26","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug\u2010like molecules compatible with the CHARMM all\u2010atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.antiviral.2026.106550_bib27","article-title":"The epidemiology, virology, and pathogenicity of human infections with avian influenza viruses","volume":"1","author":"Wang","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.antiviral.2026.106550_bib28","doi-asserted-by":"crossref","first-page":"826","DOI":"10.7150\/thno.17071","article-title":"Progress of small molecular inhibitors in the development of anti-influenza virus agents","volume":"7","author":"Wu","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.antiviral.2026.106550_bib29","first-page":"18431","volume":"117","author":"Yao","year":"2020"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226002093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354226002093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:24:13Z","timestamp":1794086653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354226002093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":28,"alternative-id":["S0166354226002093"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106550","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel antiviral drug candidate acts by binding to the hemagglutinin stem","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2026.106550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106550"}}